Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease

Prostate cancer (PCa) is a major diagnosed cancer among men globally, and about 20% of patients develop metastatic prostate cancer (mPCa) in the initial diagnosis. PCa is a typical androgen-dependent disease; thus, hormonal therapy is commonly used as a standard care for mPCa by inhibiting androgen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo-Ren, Chen, Yu-An, Kao, Wei-Hsiang, Lai, Chih-Ho, Lin, Ho, Hsieh, Jer-Tsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405166/
https://www.ncbi.nlm.nih.gov/pubmed/36009418
http://dx.doi.org/10.3390/biomedicines10081872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405166/
https://www.ncbi.nlm.nih.gov/pubmed/36009418
http://dx.doi.org/10.3390/biomedicines10081872

Ejemplares similares